Tykerb News
Most Popular Tykerb Story
Tykerb - 2007 FDA approvals
Drug: Tykerb (lapatinib) Indication: Metastatic breast cancer Company: GlaxoSmithKline Approval Date: March 13, 2007 Scoop: The FDA gave its approval to Tykerb for metastatic breast cancer in Read more...
Latest Headlines
- January 8, 2008
- November 15, 2006
- June 4, 2006
- May 23, 2006
- April 2, 2006
- November 29, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
